Almohareb, S.N.; Alfayez, O.M.; Aljuaid, S.S.; Alshahrani, W.A.; Bakhsh, G.; Alshammari, M.K.; Al Yami, M.S.; Alshaya, O.A.; Alomran, A.S.; Korayem, G.B.;
et al. Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes. J. Clin. Med. 2024, 13, 6532.
https://doi.org/10.3390/jcm13216532
AMA Style
Almohareb SN, Alfayez OM, Aljuaid SS, Alshahrani WA, Bakhsh G, Alshammari MK, Al Yami MS, Alshaya OA, Alomran AS, Korayem GB,
et al. Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes. Journal of Clinical Medicine. 2024; 13(21):6532.
https://doi.org/10.3390/jcm13216532
Chicago/Turabian Style
Almohareb, Sumaya N., Osamah M. Alfayez, Shoroq S. Aljuaid, Walaa A. Alshahrani, Ghalia Bakhsh, Mohammed K. Alshammari, Majed S. Al Yami, Omar A. Alshaya, Abdullah S. Alomran, Ghazwa B. Korayem,
and et al. 2024. "Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes" Journal of Clinical Medicine 13, no. 21: 6532.
https://doi.org/10.3390/jcm13216532
APA Style
Almohareb, S. N., Alfayez, O. M., Aljuaid, S. S., Alshahrani, W. A., Bakhsh, G., Alshammari, M. K., Al Yami, M. S., Alshaya, O. A., Alomran, A. S., Korayem, G. B., & Almohammed, O. A.
(2024). Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes. Journal of Clinical Medicine, 13(21), 6532.
https://doi.org/10.3390/jcm13216532
